Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
$2.93
+1.0%
$3.33
$1.72
$3.84
$27.53M1.4925,978 shs2,465 shs
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
$0.22
$0.22
$0.22
$8.16
$1.70M0.691,500 shsN/A
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
$2.18
-7.2%
$2.22
$1.56
$4.08
$18.62M1.2870,124 shs29,128 shs
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
$14.73
+0.1%
$14.71
$11.53
$15.89
$214.03M1.43110,789 shs82,841 shs
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$1.51
+1.3%
$1.51
$1.16
$6.24
$44.33M1.17212,713 shs210,170 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
+2.08%-7.26%-13.78%+23.01%+3.14%
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
-5.62%-11.65%-3.69%+40.72%-10.65%
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
-0.14%+0.20%-0.14%+10.60%+21.57%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-2.61%+0.68%-8.02%+7.97%-31.96%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
1.9314 of 5 stars
3.53.00.00.00.60.81.3
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
2.7866 of 5 stars
3.55.00.00.01.51.70.6
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.8291 of 5 stars
3.55.00.04.10.60.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
3.00
Buy$6.00104.88% Upside
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
N/AN/AN/AN/A
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
3.00
Buy$12.00450.46% Upside
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
N/AN/AN/AN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.00
Buy$7.00363.58% Upside

Current Analyst Ratings

Latest INDP, RMTI, ACST, MACK, and ASPCF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
3/25/2024
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $9.00
2/7/2024
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
N/AN/AN/AN/A$9.14 per shareN/A
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
$2.12M0.80N/AN/A($3.38) per share-0.07
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
N/AN/AN/AN/A$1.44 per shareN/A
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
N/AN/AN/AN/A$1.31 per shareN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$83.61M0.53$0.02 per share78.82$0.75 per share2.01

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
-$42.43M-$5.08N/AN/AN/AN/A-13.18%-11.32%6/28/2024 (Estimated)
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
-$33.82M-$3.57N/AN/A-924.33%N/A-74.62%N/A
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
-$15.42M-$1.84N/AN/AN/AN/A-91.78%-80.42%5/9/2024 (Estimated)
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
-$1.18M-$0.08N/AN/AN/A-6.24%-6.09%5/2/2024 (Estimated)
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$8.44M-$0.40N/A25.17N/A-10.09%-39.17%-13.87%5/14/2024 (Confirmed)

Latest INDP, RMTI, ACST, MACK, and ASPCF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2024N/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$0.05N/A+$0.05N/AN/AN/A  
3/21/2024Q4 2023
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$0.08$0.02+$0.10$0.09$22.09 million$22.09 million
3/13/2024Q4 2023
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
-$0.54-$0.47+$0.07-$0.47N/AN/A
3/7/2024Q4 2023
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
N/A-$0.01-$0.01-$0.01N/AN/A
2/12/202412/31/2023
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
-$0.23-$0.21+$0.02-$0.21N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
N/AN/AN/AN/AN/A
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
N/AN/AN/AN/AN/A
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
N/AN/AN/AN/AN/A
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
N/AN/AN/AN/AN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
N/A
15.19
15.19
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
N/A
0.67
0.34
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
N/A
5.05
5.05
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
N/A
43.50
43.50
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
0.46
1.73
1.38

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
329.40 million8.13 millionNot Optionable
Acerus Pharmaceuticals Co. stock logo
ASPCF
Acerus Pharmaceuticals
147.71 millionN/ANot Optionable
Indaptus Therapeutics, Inc. stock logo
INDP
Indaptus Therapeutics
78.54 million6.23 millionNot Optionable
Merrimack Pharmaceuticals, Inc. stock logo
MACK
Merrimack Pharmaceuticals
42614.53 million10.34 millionOptionable
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
23729.36 million28.72 millionOptionable

INDP, RMTI, ACST, MACK, and ASPCF Headlines

SourceHeadline
Rockwell Medical, Inc. (RMTI)Rockwell Medical, Inc. (RMTI)
finance.yahoo.com - April 21 at 4:13 PM
Rockwell Medical Continues to Expand its Distribution Capabilities in Western United StatesRockwell Medical Continues to Expand its Distribution Capabilities in Western United States
finance.yahoo.com - April 17 at 7:50 AM
Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024
businesswire.com - April 16 at 6:00 AM
Rockwell Medical gains as global reach widensRockwell Medical gains as global reach widens
msn.com - April 4 at 5:50 PM
Rockwell Medical Expands Global Distribution in the Dominican Republic and BermudaRockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
businesswire.com - April 4 at 6:00 AM
Rockwell Medical (RMTI) Increases Despite Market Slip: Heres What You Need to KnowRockwell Medical (RMTI) Increases Despite Market Slip: Here's What You Need to Know
zacks.com - March 26 at 7:21 PM
Rockwell Medical Full Year 2023 Earnings: EPS Beats ExpectationsRockwell Medical Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - March 26 at 5:55 PM
Q4 2024 EPS Estimates for Rockwell Medical, Inc. (NASDAQ:RMTI) Decreased by AnalystQ4 2024 EPS Estimates for Rockwell Medical, Inc. (NASDAQ:RMTI) Decreased by Analyst
marketbeat.com - March 26 at 7:54 AM
Rockwell Medical (NASDAQ:RMTI) Price Target Cut to $9.00Rockwell Medical (NASDAQ:RMTI) Price Target Cut to $9.00
marketbeat.com - March 25 at 8:21 AM
Rockwell Medical Named Great Place to Work for Second Year in a RowRockwell Medical Named 'Great Place to Work' for Second Year in a Row
businesswire.com - March 25 at 6:00 AM
Analysts Have Been Trimming Their Rockwell Medical, Inc. (NASDAQ:RMTI) Price Target After Its Latest ReportAnalysts Have Been Trimming Their Rockwell Medical, Inc. (NASDAQ:RMTI) Price Target After Its Latest Report
finance.yahoo.com - March 24 at 7:36 PM
Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call TranscriptRockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 23 at 9:36 PM
Buy Rating Reaffirmed for Rockwell Med amidst Strategic Growth and Operational EfficiencyBuy Rating Reaffirmed for Rockwell Med amidst Strategic Growth and Operational Efficiency
markets.businessinsider.com - March 23 at 11:34 AM
Q4 2023 Rockwell Medical Inc Earnings CallQ4 2023 Rockwell Medical Inc Earnings Call
finance.yahoo.com - March 22 at 3:17 AM
Rockwell Medical: Q4 Earnings InsightsRockwell Medical: Q4 Earnings Insights
benzinga.com - March 21 at 11:32 AM
Rockwell Medical Shares Rise After Narrower 4Q Loss, Higher SalesRockwell Medical Shares Rise After Narrower 4Q Loss, Higher Sales
marketwatch.com - March 21 at 11:32 AM
RMTI Stock Earnings: Rockwell Medical Beats EPS, Misses Revenue for Q4 2023RMTI Stock Earnings: Rockwell Medical Beats EPS, Misses Revenue for Q4 2023
msn.com - March 21 at 11:32 AM
Rockwell Medical (RMTI) Q4 Earnings and Revenues Beat EstimatesRockwell Medical (RMTI) Q4 Earnings and Revenues Beat Estimates
zacks.com - March 21 at 8:11 AM
Rockwell Medical: Q4 Earnings SnapshotRockwell Medical: Q4 Earnings Snapshot
sfgate.com - March 21 at 6:32 AM
Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023
businesswire.com - March 21 at 6:00 AM
Rockwell Medical earnings preview: what Wall Street is expectingRockwell Medical earnings preview: what Wall Street is expecting
markets.businessinsider.com - March 20 at 3:29 PM
Rockwell Medical Inc Registered Shs hosts conference call for investorsRockwell Medical Inc Registered Shs hosts conference call for investors
markets.businessinsider.com - March 18 at 2:59 AM
Rockwell Automation names new chief information security officerRockwell Automation names new chief information security officer
biztimes.com - March 13 at 7:06 PM
Rockwell Medical (RMTI) Rises As Market Takes a Dip: Key FactsRockwell Medical (RMTI) Rises As Market Takes a Dip: Key Facts
zacks.com - March 11 at 7:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Acasti Pharma logo

Acasti Pharma

NASDAQ:ACST
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acerus Pharmaceuticals logo

Acerus Pharmaceuticals

OTCMKTS:ASPCF
Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men's health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada.
Indaptus Therapeutics logo

Indaptus Therapeutics

NASDAQ:INDP
Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Merrimack Pharmaceuticals logo

Merrimack Pharmaceuticals

NASDAQ:MACK
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Rockwell Medical logo

Rockwell Medical

NASDAQ:RMTI
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.